Lipid Nanoparticle Portfolio for Enabling Non-Viral Delivery - Dr. Anitha Thomas

  Рет қаралды 1,886

Precision NanoSystems is now part of Cytiva

Precision NanoSystems is now part of Cytiva

Күн бұрын

Physico-chemical profiles of ionizable lipids will depend on application, therefore analytical evaluation is essential to validating the LNP potency and performance at each stage of drug development depending on the TPP (Target Product Profile). 
Precision NanoSystems offers a Genomic Medicine Toolkit to enable access to NxGen™️ microfluidic technologies, a novel well characterized lipid library, and scientific expertise in formulation and process development to design and optimize vehicles for nucleic acid therapeutics, thereby providing an end-to-end solution enabling future transformative genomic medicines.

Пікірлер
New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy
45:23
Precision NanoSystems is now part of Cytiva
Рет қаралды 1,6 М.
RNA-LNP Therapeutics Panel Discussion
1:30:45
Precision NanoSystems is now part of Cytiva
Рет қаралды 1 М.
UFC 310 : Рахмонов VS Мачадо Гэрри
05:00
Setanta Sports UFC
Рет қаралды 1,2 МЛН
How to treat Acne💉
00:31
ISSEI / いっせい
Рет қаралды 108 МЛН
Novel Ionizable Lipid Portfolio for Enabling Non-Viral Delivery
38:49
Precision NanoSystems is now part of Cytiva
Рет қаралды 789
Maximizing Yield and Purity in RNA-LNP Downstream Processing
1:01:44
Precision NanoSystems is now part of Cytiva
Рет қаралды 772
Lipid nanoparticles for drug delivery
13:48
Tonya Coffey
Рет қаралды 15 М.
Tim Ferriss: How to Learn Better & Create Your Best Future | Huberman Lab Podcast
3:39:09
Lipid nanoparticles for mRNA delivery
53:34
LINXS
Рет қаралды 15 М.
Optimized and Scalable LNP Composition for RNA Vaccine Delivery
43:40
Precision NanoSystems is now part of Cytiva
Рет қаралды 639